Hoechst Pakistan Reports 27% Growth in Nine-Month Profit, Announces Strategic Healthcare Partnership

Hoechst Pakistan Limited has reported a significant increase in profitability for the nine months ended September 30, 2026, while announcing a strategic partnership to introduce Dianatal® Obstetric Gel in Pakistan during the first half of 2027.

Hoechst Pakistan Limited has announced its unaudited financial results for the nine months and quarter ended September 30, 2026, reflecting improved year-on-year profitability despite a slight decline in revenue.

According to the financial statements approved by the company’s Board of Directors on October 21, 2026, the company recorded an unconsolidated net profit of Rs 2.81 billion for the nine-month period, compared with Rs 2.22 billion in the corresponding period of 2025. This represents an increase of approximately 26.6%.

Earnings per share also improved to Rs 291.34, compared with Rs 230.14 in the same period last year, highlighting stronger profitability.

Revenue and Profitability Performance

The company’s revenue from contracts with customers stood at approximately Rs 24.46 billion during the nine months ended September 30, 2026, slightly below the Rs 24.57 billion reported in the corresponding period of the previous year.

Despite the marginal revenue decline, Hoechst Pakistan improved its gross profit to approximately Rs 9.54 billion, compared with Rs 8.67 billion in the same period last year. Operating profit also increased to Rs 4.69 billion from Rs 4.08 billion.

Profit before tax reached Rs 4.74 billion, compared with Rs 3.88 billion in the corresponding period of 2025.

On a consolidated basis, the company reported a net profit of Rs 2.81 billion, against Rs 2.21 billion in the previous year. Consolidated earnings per share increased to Rs 291.07 from Rs 229.21.

However, quarterly performance showed a different trend. Unconsolidated net profit for the quarter ended September 30, 2026, stood at Rs 614.35 million, compared with Rs 875.68 million in the same quarter last year. Consolidated quarterly profit also declined to Rs 615.99 million from Rs 867.61 million.

Strategic Partnership to Introduce Dianatal® in Pakistan

Alongside its financial results, Hoechst Pakistan announced an important development in its business expansion strategy.

The company has obtained all applicable legal and regulatory approvals to distribute Dianatal® Obstetric Gel in Pakistan under an exclusive distribution agreement with Switzerland-based Tentan AG.

Dianatal® is a medical device manufactured by Tentan AG, a healthcare company with a commercial presence in multiple international markets. Commercialization of the product in Pakistan is expected to begin during the first half of 2027, subject to the commercial terms agreed between the two parties.

The partnership represents another step in Hoechst Pakistan’s medium- to long-term strategic expansion plans, which include exploring product partnerships, investments in manufacturing assets and potential acquisitions in the pharmaceutical sector.

According to the company, the collaboration is expected to expand healthcare options available to patients in Pakistan while supporting long-term value creation for the company and its shareholders.

No Dividend Announced

The Board of Directors did not recommend any cash dividend, bonus shares or right shares for the nine-month period ended September 30, 2026. No other entitlement or corporate action was announced alongside the financial results.

Outlook

Hoechst Pakistan’s latest financial performance reflects stronger year-on-year profitability, supported by improvements in gross and operating profit despite slightly lower revenue.

The upcoming launch of Dianatal® Obstetric Gel could provide an additional business opportunity as the company continues to explore strategic partnerships and expansion opportunities in Pakistan’s healthcare market.

With commercialization expected in the first half of 2027, investors and market participants will be watching how the new partnership contributes to the company’s future business performance and long-term growth strategy.

The financial results and commercial partnership announcement highlight Hoechst Pakistan’s continued focus on profitability, business development and expanding its presence in the healthcare sector.